Home » NIH-SPONSORED MACROLIDE AZITHROMYCIN COPD PHASE III STUDY UTILIZES MED-IC SMART BLISTER PACKAGING
NIH-SPONSORED MACROLIDE AZITHROMYCIN COPD PHASE III STUDY UTILIZES MED-IC SMART BLISTER PACKAGING
Information Mediary Corporation has begun to supply over 30,000 of its Med-ic RFID smart sensor labels for use in a large multi-year COPD macrolide study. The study, sponsored by NIH's National Heart, Lung, and Blood Institute (NHLBI) will be enrolling over 1100 patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), with emphasis on the prevention and management of exacerbations of the disease.
MoreRFID (http://www.morerfid.com/details.php?subdetail=Report&action=details&report_id=1023&display=RFID)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May